ARCHIVES

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

NIH News: PubMed Central Is Name Of New NIH PLAN For Electronic Publishing

September 10, 1999

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care

May 30, 2008

ACCC To Ask Congress To Earmark Appropriations For Construction Of Community Cancer Centers

January 17, 1975